Brain death evaluation during the pandemic.
Neurology
; 95(15): 693-694, 2020 10 13.
Article
in English
| MEDLINE | ID: covidwho-690840
ABSTRACT
Coronavirus disease 2019 (COVID-19) may pose unique challenges to clinicians attempting to diagnose brain death in patients infected with the SARS-CoV-2. Among these challenges is the risk of aerosol generation during the traditional apnea testing using the insufflation technique in addition to the risk of complications due to SARS-CoV-2-related lung disease. In this article, we discuss these challenges and provide further guidance to minimize such risks to ensure safety of healthcare professionals and other patients. We also emphasize the importance of maintaining the standards of brain death determination in this critical time.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Brain Death
/
Infectious Disease Transmission, Patient-to-Professional
/
Coronavirus Infections
/
Pandemics
/
Neurologic Examination
Type of study:
Diagnostic study
/
Experimental Studies
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Neurology
Year:
2020
Document Type:
Article
Affiliation country:
WNL.0000000000010544
Similar
MEDLINE
...
LILACS
LIS